Harmony Biosciences Reports First Quarter 2021 Results and Business Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Harmony Biosciences Reports First Quarter 2021 Results and Business Updates

Harmony Biosciences (HRMY) Tops Q1 EPS by 16c, Revenues Beat

May 11, 2021 8:04 AM EDT

Harmony Biosciences (NASDAQ: HRMY) reported Q1 EPS of $0.13, $0.16 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $59.7 million versus the consensus estimate of $57.07 million.

First Quarter 2021 Highlights:

Net product revenue of $59.7 million for the quarter ended March 31, 2021;Significant growth in WAKIX sales, supported by the addition of the cataplexy indication, which strengthens the overall... More